Your shopping cart is currently empty

AZD9362 is a reversible, ATP-competitive inhibitor of the insulin-like growth factor 1 receptor (IGF-1R) and the insulin receptor (insulin receptor) with oral bioavailability. It inhibits IGF-1R enzyme activity with an IC50 value of 14 nM. AZD9362 enhances the antitumor effects of AZD5363 and can be applied in cancer research, including studies on breast cancer.
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | AZD9362 is a reversible, ATP-competitive inhibitor of the insulin-like growth factor 1 receptor (IGF-1R) and the insulin receptor (insulin receptor) with oral bioavailability. It inhibits IGF-1R enzyme activity with an IC50 value of 14 nM. AZD9362 enhances the antitumor effects of AZD5363 and can be applied in cancer research, including studies on breast cancer. |
| In vivo | Administered orally at 25 mg/kg, AZD9362 enhanced the antitumor efficacy of AZD5363 in both MCF-7/LTED cells and MCF-7 xenografts in ovariectomized mice without estrogen supplementation. |
| Molecular Weight | 494.98 |
| Formula | C24H27ClN8O2 |
| Cas No. | 1905412-80-7 |
| Smiles | ClC=1C(C2=C3N(N=C2)C=CC=C3)=NC(NC4=C(C)N(N=C4C)C5CCN(C([C@@H](C)O)=O)CC5)=NC1 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.